Status:
UNKNOWN
Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery
Lead Sponsor:
Taibah University
Conditions:
Infection
Eligibility:
All Genders
16-70 years
Phase:
NA
Brief Summary
There was no evidence to judge the effects of preventative antibiotics for extractions of severely decayed teeth, teeth in diseased gums, or extractions in patients who are sick or have low immunity t...
Detailed Description
A comparison of single preoperative dose of Co-amoxiclav versus postoperative full course of Amoxicillin/ Co-amoxiclav in prevention of postoperative complications in dentoalveolar surgery: a randomiz...
Eligibility Criteria
Inclusion
- Patient age from 16 to 70 yrs old
- Patient needs surgical teeth extraction (subject tooth will be removed using osteotomy by motorised drill).
Exclusion
- Patients refusing the preoperative dose of oral co-amoxiclav, and unwilling to take part .
- Patients who are allergic to co-amoxiclve, amoxicillin or metronidazole
- Patient are on warfarin medication
Key Trial Info
Start Date :
October 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 20 2021
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT03844776
Start Date
October 2 2019
End Date
January 20 2021
Last Update
October 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taibah University
Madinah, Saudi Arabia, 41311